Drug Shortage Report for SODIUM PHOSPHATES INJECTION USP

Last updated on 2023-11-28 History
Report ID 200953
Drug Identification Number 00896187
Brand name SODIUM PHOSPHATES INJECTION USP
Common or Proper name SODIUM HYDROGEN PHOSPHATE+SODIUM DIHYDROGEN PHOSPHATE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) SODIUM PHOSPHATE DIBASIC SODIUM PHOSPHATE MONOBASIC
Strength(s) 268MG 276MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10ML 10LIVI
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2023-08-03
Estimated end date 2023-11-03
Actual end date 2023-11-27
Shortage status Resolved
Updated date 2023-11-28
Company comments Baxter code : 7990. Product is available under allocation based on 100% of historical volumes.
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2023-11-28 English Compare
v11 2023-11-27 French Compare
v10 2023-11-27 English Compare
v9 2023-09-21 French Compare
v8 2023-09-21 English Compare
v7 2023-09-11 French Compare
v6 2023-09-11 English Compare
v5 2023-08-04 English Compare
v4 2023-08-03 French Compare
v3 2023-08-03 English Compare
v2 2023-08-03 English Compare
v1 2023-08-03 English Compare

Showing 1 to 12 of 12